Billing Requirements for Ophthalmic Bevacizumab

As of October 1, 2017, claims for ophthalmic bevacizumab (Avastin®) can no longer be processed when billed using the HCPCS code J3590 (unclassified biologics).

When submitting a claim for the ophthalmic use of bevacizumab, report 1 unit of HCPCS code J9035 (Injection, bevacizumab, 10 mg) per eye injected with the appropriate modifier -LT (left eye), -RT (right eye). For bilateral injections, report 1 unit per eye with -LT and -RT modifiers.

Contact Palmetto GBA JM Part B Medicare

Email Part B

Contact a specific JM Part B department

Provider Contact Center: 855-696-0705

TDD: 866-830-3188

Other Palmetto GBA Sites

Palmetto GBA Home

DMEPOS Competitive Bidding Program

Jurisdiction J Part A MAC

Jurisdiction J Part B MAC

Jurisdiction M Part A MAC

Jurisdiction M Part B MAC

Jurisdiction M Home Health and Hospice MAC

MolDX

National Supplier Clearinghouse MAC

PDAC

RRB Specialty MAC Providers

RRB Specialty MAC Beneficiaries

Anonymous

 

Click to Chat Now